This is all to do with the placement of A$11 shares at 0.2695....

This is all to do with the placement of A$11 shares at 0.2695. This has pulled the price back to this level. Understandby price has dropped. They have now retired their convertible note debt, which was what pulled the prices down from $1 - 80c in the first place. So now they are a clean slate. Their debts are paid and they are in a better financial position. With the money to come from Pfizer, on top of their existing market share, this stock will double up in the next 2 - 4 weeks. If you can buy at 27c, 28c etc....then you've bought a bargain.
*I'm no analyst or IR, DYOR*